简介：2007年是中国房市最牛的一年，在人们对“史上最牛钉子户”的新闻还记忆犹新的时候．迟子建的小说《起舞》引入注目，也在意料之中。这篇小说一反迟子建以往简练明净的风格，将目光投向新鲜的现实和尚在保鲜期的历史，一开始就是哈尔滨城市历史的铺陈，让人想起了王安忆《长恨歌》的冗长开篇；

简介：摘要目的讨论肺结核治疗与控制。方法对患者进行治疗并预防控制疾病传染。结论确诊的结核病病人应及时给予抗结核药物治疗、合理的化疗，此是治愈病人、消除传染源、控制流行的最有效措施。严格执行在医务人员监视下的短程化疗(D0TS)是化疗成功的关键。应用化疗的原则是早期、联合、适量、规律和全程用药。结核病主要由呼吸道传播及感染，可累及全身各器官，尤以肺结核最为多见。痰中排菌的肺结核病人属传染性肺结核，是造成社会传播和流行的传染源，是控制的首要对象。

简介：摘要目的讨论肺结核的药物治疗。方法根据患者的病情选用不同的药物进行治疗。结论目前国际上通用的抗结核药物有十余种，一般可分为基本抗结核药物(即一线药物)及次要抗结核药物(即二线抗结核药物，复治用药)两大类。基本抗结核药物包括异烟肼、利福平、利福喷丁、吡嗪酰胺、链霉素、乙胺丁醇；次要抗结核药物共包括卡那霉素、丁胺卡那、卷曲霉素、对氨基水杨酸、丙硫异烟胺、β-内酰胺类与β-内酰胺酶抑制复合剂、新大环内酯类抗生素。

简介：

简介：摘要目的讨论结核性腹膜炎的药物治疗。方法根据患者具体情况采用药物进行治疗。结论常用抗结核药物中最常用的有(一线药物)异烟肼、利福平、链霉素、吡嗪酰胺、乙胺丁醇；其他还有(二线药物)卡那霉素、卷曲霉素、紫霉素、对氨水杨酸、乙(丙)硫异烟胺(1314TH、1321TH)、环丝氨酸、氨硫脲、氟喹诺酮类(氧氟沙星、左氧氟沙星)、利福布汀、帕司烟肼等。

简介：　　【摘要】 目的 分析左氧氟沙星联合抗结核药物治疗肺结核合并肺部感染患者的临床效果。方法 64例肺结核合并肺部感染患者， 采用抽签法分为对照组与实验组， 每组 32例。对照组患者接受常规抗结核药物治疗， 实验组患者接受左氧氟沙星联合抗结核药物治疗。比较两组患者并发症发生情况、治疗效果。结果 实验组患者并发症发生率 9.38%低于对照组的 31.25%， 总有效率 90.63%高于对照组的 75.00%， 差异有统计学意义（ P<0.05）。结论 采用左氧氟沙星联合抗结核药物治疗肺结核合并肺部感染患者效果显著， 可有效预防并发症， 安全性高， 可在临床推广及使用。  　　【关键词】 左氧氟沙星 ;抗结核药物 ;肺结核 ;肺部感染  　　 [Abstract] Objective To analyze the clinical effect of levofloxacin combined with anti tuberculosis drugs in the treatment of pulmonary tuberculosis complicated with pulmonary infection. Methods 64 patients with pulmonary tuberculosis complicated with pulmonary infection were randomly divided into control group and experimental group, 32 cases in each group. The control group received conventional anti tuberculosis drug treatment, and the experimental group received levofloxacin combined with anti tuberculosis drugs. The complications and treatment effect of the two groups were compared. Results the incidence of complications in the experimental group was 9.38%, which was lower than 31.25% of the control group, and the total effective rate was 90.63% higher than 75.00% of the control group, the difference was statistically significant (P < 0.05). Conclusion levofloxacin combined with antituberculosis drugs in the treatment of pulmonary tuberculosis complicated with pulmonary infection has significant effect, can effectively prevent complications, high safety, can be popularized and used in clinic.

简介：　　【摘 要】 目的：分析肺结核伴咯血者以酚妥拉明、垂体后叶素配合治疗的有效性。方法：以 2018.5～ 2020.3期间 100例肺结核伴咯血为研究对象，所有患者均给予常规治疗，同时按治疗小组不同分组，对照组共 48例（采用垂体后叶素）、观察组 52例（酚妥拉明 +垂体后叶素），观察不同用药临床疗效差异，比较两组止血时间、咯血量，统计治疗期间用药所致不良反应。结果：观察组治疗率为 94.2%高于对照组 85.4%， P<0.05;两组止血情况，观察组止血用时短于对照组，咯血量少于对照组， P<0.05;两组不良反应情况比较，观察组发生率为 11.5%低于对照组 25.0%， P<0.05。结论：肺结核咯血者以酚妥拉明、垂体后叶素配合治疗，临床疗效理想，患者咯血症状改善快、咯血量少，且用药不良反应少，可推广应用。  　　【关键词】 咯血 ;垂体后叶素 ;疗效 ;肺结核 ;酚妥拉明  Objective: to analyze the efficacy of phentolamine and pituitrin in the treatment of pulmonary tuberculosis with hemoptysis. Methods: 100 cases of pulmonary tuberculosis with hemoptysis from May 2018 to March 2020 were selected as the research objects. All patients were given conventional treatment. At the same time, according to the different treatment groups, 48 cases in the control group (pituitrin) and 52 cases (phentolamine + pituitrin) in the observation group. The clinical efficacy differences of different drugs were observed. The hemostatic time and hemoptysis volume of the two groups were compared, and the medication during the treatment was counted Adverse reactions were caused. Results: the treatment rate of the observation group was 94.2%, which was higher than 85.4% of the control group, P < 0.05; the hemostasis time of the observation group was shorter than that of the control group, and the hemoptysis volume was less than that of the control group, P < 0.05; the incidence of adverse reactions in the observation group was 11.5%, lower than that in the control group 25.0%, P < 0.05. Conclusion: the clinical effect of phentolamine and pituitrin in the treatment of pulmonary tuberculosis hemoptysis is ideal. The symptoms of hemoptysis are improved quickly, the amount of hemoptysis is less, and the adverse reaction of medication is less, which can be popularized and applied.